Drug name - Folotyn

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6028071 ACROTECH Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
Jul, 2022

(2 months ago)

EP944389A1 ACROTECH Purified Compositions Of 10-Propargyl-10-Deazaaminopterin And Methods Of Using Same In The Treatment Of Tumors
Jul, 2017

(5 years ago)

EP944389B1 ACROTECH Purified Compositions Of 10-Propargyl-10-Deazaaminopterin And Methods Of Using Same In The Treatment Of Tumors
Jul, 2017

(5 years ago)

EP944389A4 ACROTECH Purified Compositions Of 10-Propargyl-10-Deazaaminopterin And Methods Of Using Same In The Treatment Of Tumors
Jul, 2017

(5 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8299078 ACROTECH Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin May, 2025

(2 years from now)

US7622470 ACROTECH Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin May, 2025

(2 years from now)

Drugs and Companies using PRALATREXATE ingredient

Treatment: Treatment of patients with relapsed or refractory peripheral t-cell lymphoma

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
20MG/ML (20MG/ML) SOLUTION;INTRAVENOUS Prescription
40MG/2ML (20MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.